Astrana Health, Inc.

ASTH · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$0$9$6-$8
Dep. & Amort.$16$7$7$8
Deferred Tax-$3-$2-$0$3
Stock-Based Comp.$0$0$8$15
Change in WC-$15$60-$8-$30
Other Non-Cash$12$17$4-$0
Operating Cash Flow$10$91$17-$11
Investing Activities
PP&E Inv.-$3-$1-$3-$3
Net Acquisitions-$549$0$0-$35
Inv. Purchases$0$0-$0$4
Inv. Sales/Matur.$15-$0$0$0
Other Inv. Act.$2$0$1$0
Investing Cash Flow-$534-$1-$2-$33
Financing Activities
Debt Repay.$673-$3-$16-$4
Stock Issued$0-$0$0$0
Stock Repurch.$0$1-$1-$0
Dividends Paid-$0-$1-$5-$2
Other Fin. Act.-$24-$6-$21-$9
Financing Cash Flow$648-$9-$44-$15
Forex Effect-$1$0$0$0
Net Chg. in Cash$123$81-$30-$60
Supplemental Information
Beg. Cash$340$259$289$349
End Cash$462$340$259$289
Free Cash Flow$7$89$14-$13